DekaBank Deutsche Girozentrale
AERI

DekaBank Deutsche Girozentrale’s Aerie Pharmaceuticals AERI Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,100
Closed -$136K – 1513
2021
Q3 		$136K Hold
12,100
– – ﹤0.01% 1263
2021
Q2 		$198K Hold
12,100
– – ﹤0.01% 1220
2021
Q1 		$215K Hold
12,100
– – ﹤0.01% 1173
2020
Q4 		$161K Hold
12,100
– – ﹤0.01% 1209
2020
Q3 		$136K Buy
+12,100
New +$147K ﹤0.01% 1096
2019
Q4 		– Sell
-12,400
Closed -$252K – 1244
2019
Q3 		$252K Sell
12,400
-12,400
-50% -$284K ﹤0.01% 829
2019
Q2 		$720K Buy
24,800
+9,600
+63% +$370K ﹤0.01% 856
2019
Q1 		$948K Buy
15,200
+2,800
+23% +$123K 0.01% 778
2018
Q4 		$443K Sell
12,400
-2,800
-18% -$131K ﹤0.01% 848
2018
Q3 		$948K Sell
15,200
-400
-3% -$25.7K 0.01% 793
2018
Q2 		$1.05M Hold
15,600
– – 0.01% 739
2018
Q1 		$838K Sell
15,600
-300
-2% -$16.8K 0.01% 759
2017
Q4 		$830K Hold
15,900
– – 0.01% 729
2017
Q3 		$830K Hold
15,900
– – 0.01% 737
2017
Q2 		$851K Hold
15,900
– – 0.01% 732
2017
Q1 		$723K Sell
15,900
-1,300
-8% -$58K 0.01% 667
2016
Q4 		$650K Buy
17,200
+1,300
+8% +$49.2K 0.01% 618
2016
Q3 		$599K Hold
15,900
– – 0.01% 637
2016
Q2 		$286K Buy
15,900
+2,400
+18% +$38.9K ﹤0.01% 795
2016
Q1 		$164K Buy
13,500
+400
+3% +$6.33K ﹤0.01% 881
2015
Q4 		$320K Buy
13,100
+300
+2% +$7K ﹤0.01% 786
2015
Q3 		$227K Buy
12,800
+1,100
+9% +$19.9K ﹤0.01% 844
2015
Q2 		$207K Buy
11,700
+400
+4% +$7.33K ﹤0.01% 883
2015
Q1 		$354K Buy
+11,300
New +$328K ﹤0.01% 793

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

DekaBank Deutsche Girozentrale's AERI Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Aerie Pharmaceuticals (AERI) in Q4 2021, closing a stake of 12,100 shares — an estimated $136K sold.

DekaBank Deutsche Girozentrale first reported a position in AERI in Q1 2015 and held it in 24 quarters. The position peaked at $1.05M in Q2 2018. 129 funds tracked by Wall St. Rank hold AERI as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Aerie Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 12,100 Aerie Pharmaceuticals shares in Q4 2021, an estimated $136K.
  • DekaBank Deutsche Girozentrale first reported a position in Aerie Pharmaceuticals in Q1 2015 and held it in 24 quarters.
  • DekaBank Deutsche Girozentrale's Aerie Pharmaceuticals position peaked at $1.05M in Q2 2018.
  • 129 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.